J&J Products - LARVOL Sigma


Phase N/A 1 2 3 4 Trials	0	70140210280350420490560630700



RV1729 / J&J




Uptravi Injection (selexipag IV) / J&J, Nippon Shinyaku




VE202 / Vedanta Biosci




entacingene turiparvovec (AAV-CNGB3) / J&J




intetumumab (CNTO 95) / J&J




mibenratide (COR1) / J&J




plamotamab (XmAb13676) / Xencor




ACH-3422 / J&J, AstraZeneca




ALS-2158 / J&J, Vertex




ARO-PNPLA3 / Arrowhead




CSL730 / CSL Behring, J&J




Clade C and Mosaic gp140 HIV bivalent vaccine / J&J




EVT 101 / J&J




Evorel (estradiol transdermal) / J&J




JNJ-2056 / J&J




JNJ-26366821 / J&J




JNJ-37822681 / J&J




JNJ-4703 / J&J




JNJ-5322 / J&J




JNJ-5939 / J&J




JNJ-64213175 / J&J




JNJ-6665 / J&J




JNJ-8902 / J&J, Genmab




P-BCMA-101 / Poseida Therap




PF-05236812 / J&J, Pfizer




PN-232 / J&J




RWJ-445380 / J&J




TMC649 / J&J, Medivir




VTP-500 / J&J, University of Oxford




Yesafili (aflibercept-jbvf) / J&J, Biocon




erzotabart (GEN3014) / Genmab




esketamine IV (JNJ-54135419 IV) / J&J




lorpucitinib (JNJ-64251330) / J&J




onametostat (JNJ-64619178) / J&J




opolimogene capmilisbac (ADU-741) / Novartis




seocalcitol (CB1089) / J&J




111In-DOTA-h11B6 / J&J




AC-083 / J&J




AN1792 / J&J, Pfizer




BMS-986209 / BMS




CNTO 5825 / J&J




CR665 / Tvardi Therap




Curcusome-RA / UniQuest, J&J




DO-2 / DeuterOncology




EXN407 / Exonate, J&J




ISIS 325568 / J&J, Ionis




JACI-35.054 / AC Immune, J&J




JNJ-0631 / J&J




JNJ-17166864 / J&J




JNJ-26483327 / J&J



	Diseases Companies Products Productz Mechanisms of Action Sites